Immortality, but not oncogenic transformation, of primary human cells leads to epigenetic reprogramming of DNA methylation and gene expression

Nucleic Acids Research

Volumn 42, Issue 6, 2014, Pages 3529-3541

  Gordon, Katrina ^a,b   Clouaire, Thomas ^a,c   Bao, Xun X ^a   Kemp, Sadie E ^a   Xenophontos, Maria ^a,d   De Las Heras, Jose Ignacio ^a   Stancheva, Irina ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c Université de Toulouse Paul Sabatier   (France)

^d EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL LINE; CELL LINE, TRANSFORMED; CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; HUMANS; MALE; MICE; NIH 3T3 CELLS; ONCOGENES; PROMOTER REGIONS, GENETIC;

EID: 84899017391     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt1351     Document Type: Article

References (46)

1. Jones, P. A. and Baylin, S. B. (2002) The fundamental role of epigenetic events in cancer. Nat. Rev. Genet., 3, 415-428.
2. Jones, P. A. and Baylin, S. B. (2007) The epigenomics of cancer. Cell, 128, 683-692.
3. Baylin, S. B. and Jones, P. A. (2011) A decade of exploring the cancer epigenome-biological and translational implications. Nat. Rev. Cancer, 11, 726-734.
4. Esteller, M. (2008) Epigenetics in cancer. N. Engl. J. Med., 358, 1148-1159.
5. Ehrlich, M. (2009) DNA hypomethylation in cancer cells. Epigenomics, 1, 239-259.
6. Hon, G. C., Hawkins, R. D., Caballero, O. L., Lo, C., Lister, R., Pelizzola, M., Valsesia, A., Ye, Z., Kuan, S., Edsall, L. E. et al. (2012) Global DNA hypomethylation coupled to repressive chromatin domain formation and gene silencing in breast cancer. Genome Res., 22, 246-258.
7. Visvader, J. E. and Lindeman, G. J. (2008) Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer, 8, 755-768.
8. Selamat, S. A., Chung, B. S., Girard, L., Zhang, W., Zhang, Y., Campan, M., Siegmund, K. D., Koss, M. N., Hagen, J. A., Lam, W. L. et al. (2012) Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression. Genome Res., 22, 1197-1211.
9. Fackler, M. J., Umbricht, C. B., Williams, D., Argani, P., Cruz, L. A., Merino, V. F., Teo, W. W., Zhang, Z., Huang, P., Visvananthan, K. et al. (2011) Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res., 71, 6195-6207.
10. Hinoue, T., Weisenberger, D. J., Lange, C. P., Shen, H., Byun, H. M., Van Den Berg, D., Malik, S., Pan, F., Noushmehr, H., van Dijk, C. M. et al. (2012) Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res., 22, 271-282.
11. Kobayashi, Y., Absher, D. M., Gulzar, Z. G., Young, S. R., McKenney, J. K., Peehl, D. M., Brooks, J. D., Myers, R. M. and Sherlock, G. (2011) DNA methylation profiling reveals novel biomarkers and important roles for DNA methyltransferases in prostate cancer. Genome Res., 21, 1017-1027.
12. Brena, R. M. and Costello, J. F. (2007) Genome-epigenome interactions in cancer. Hum. Mol. Genet., 16, R96-R105.
13. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W. and Weinberg, R. A. (1999) Creation of human tumour cells with defined genetic elements. Nature, 400, 464-468.
14. Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E. et al. (2007) Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Nat. Genet., 39, 232-236.
15. Gal-Yam, E. N., Egger, G., Iniguez, L., Holster, H., Einarsson, S., Zhang, X., Lin, J. C., Liang, G., Jones, P. A. and Tanay, A. (2008) Frequent switching of polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line. Proc. Natl Acad. Sci. USA, 105, 12979-12984.
16. Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I. et al. (2007) Epigenetic stem cell signature in cancer. Nat. Genet., 39, 157-158.
17. Myant, K., Termanis, A., Sundaram, A. Y., Boe, T., Li, C., Merusi, C., Burrage, J., de Las Heras, J. I. and Stancheva, I. (2011) LSH and G9a/GLP complex are required for developmentally programmed DNA methylation. Genome Res., 21, 83-94.
18. Illingworth, R., Kerr, A., Desousa, D., Jorgensen, H., Ellis, P., Stalker, J., Jackson, D., Clee, C., Plumb, R., Rogers, J. et al. (2008) A novel CpG island set identifies tissue-specific methylation at developmental gene loci. PLoS Biol., 6, e22.
19. Clouaire, T., Webb, S., Skene, P., Illingworth, R., Kerr, A., Andrews, R., Lee, J. H., Skalnik, D. and Bird, A. (2012) Cfp1 integrates both CpG content and gene activity for accurate H3K4me3 deposition in embryonic stem cells. Genes Dev., 26, 1714-1728.
20. Feil, R., Charlton, J., Bird, A. P., Walter, J. and Reik, W. (1994) Methylation analysis on individual chromosomes: improved protocol for bisulphite genomic sequencing. Nucleic Acids Res., 22, 695-696.
21. Suzuki, M. M., Kerr, A. R., De Sousa, D. and Bird, A. (2007) CpG methylation is targeted to transcription units in an invertebrate genome. Genome Res., 17, 625-631.
22. Li, L. C. (2007) Designing PCR primer for DNA methylation mapping. Methods Mol. Biol., 402, 371-384.
23. Bock, C., Reither, S., Mikeska, T., Paulsen, M., Walter, J. and Lengauer, T. (2005) BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics, 21, 4067-4068.
24. Mohn, F., Weber, M., Schubeler, D. and Roloff, T. C. (2009) Methylated DNA immunoprecipitation (MeDIP). Methods Mol. Biol., 507, 55-64.
25. Pfaffl, M. W. (2001) A new mathematical model for relative quantification in real-time RT-PC R. Nucleic Acids Res., 29, e45.
26. Huang da, W., Sherman, B. T. and Lempicki, R. A. (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc., 4, 44-57.
27. Taylor, L. M., James, A., Schuller, C. E., Brce, J., Lock, R. B. and Mackenzie, K. L. (2004) Inactivation of p16INK4a, with retention of pRB and p53/p21cip1 function, in human MRC5 fibroblasts that overcome a telomere-independent crisis during immortalization. J. Biol. Chem., 279, 43634-43645.
28. Ahuja, D., Saenz-Robles, M. T. and Pipas, J. M. (2005) SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation. Oncogene, 24, 7729-7745.
29. Thullberg, M., Gad, A., Le Guyader, S. and Stromblad, S. (2007) Oncogenic H-Ras V12 promotes anchorage-independent cytokinesis in human fibroblasts. Proc. Natl Acad. Sci. USA, 104, 20338-20343.
30. Mohn, F., Weber, M., Rebhan, M., Roloff, T. C., Richter, J., Stadler, M. B., Bibel, M. and Schubeler, D. (2008) Lineage-specific polycomb targets and de novo DNA methylation define restriction and potential of neuronal progenitors. Mol. Cell, 30, 755-766.
31. Carrozza, M. J., Li, B., Florens, L., Suganuma, T., Swanson, S. K., Lee, K. K., Shia, W. J., Anderson, S., Yates, J., Washburn, M. P. et al. (2005) Histone H3 methylation by Set2 directs deacetylation of coding regions by Rpd3S to suppress spurious intragenic transcription. Cell, 123, 581-592.
32. Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T. K., Koche, R. P. et al. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature, 448, 553-560.
33. Hawkins, R. D., Hon, G. C., Lee, L. K., Ngo, Q., Lister, R., Pelizzola, M., Edsall, L. E., Kuan, S., Luu, Y., Klugman, S. et al. (2010) Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell, 6, 479-491.
34. Ferrari, R., Pellegrini, M., Horwitz, G. A., Xie, W., Berk, A. J. and Kurdistani, S. K. (2008) Epigenetic reprogramming by adenovirus e1a. Science, 321, 1086-1088.
35. Horwitz, G. A., Zhang, K., McBrian, M. A., Grunstein, M., Kurdistani, S. K. and Berk, A. J. (2008) Adenovirus small e1a alters global patterns of histone modification. Science, 321, 1084-1085.
36. Sproul, D., Nestor, C., Culley, J., Dickson, J. H., Dixon, J. M., Harrison, D. J., Meehan, R. R., Sims, A. H. and Ramsahoye, B. H. (2011) Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer. Proc. Natl Acad. Sci. USA, 108, 4364-4369.
37. Sproul, D., Kitchen, R. R., Nestor, C. E., Dixon, J. M., Sims, A. H., Harrison, D. J., Ramsahoye, B. H. and Meehan, R. R. (2012) Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol., 13, R84.
38. Keshet, I., Schlesinger, Y., Farkash, S., Rand, E., Hecht, M., Segal, E., Pikarski, E., Young, R. A., Niveleau, A., Cedar, H. et al. (2006) Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet., 38, 149-153.
39. De Carvalho, D. D., Sharma, S., You, J. S., Su, S. F., Taberlay, P. C., Kelly, T. K., Yang, X., Liang, G. and Jones, P. A. (2012) DNA methylation screening identifies driver epigenetic events of cancer cell survival. Cancer Cell, 21, 655-667.
40. Gazin, C., Wajapeyee, N., Gobeil, S., Virbasius, C. M. and Green, M. R. (2007) An elaborate pathway required for Rasmediated epigenetic silencing. Nature, 449, 1073-1077.
41. Mei, F. C., Young, T. W., Liu, J. and Cheng, X. (2006) RASmediated epigenetic inactivation of OPCML in oncogenic transformation of human ovarian surface epithelial cells. FASEB J., 20, 497-499.
42. Landan, G., Cohen, N. M., Mukamel, Z., Bar, A., Molchadsky, A., Brosh, R., Horn-Saban, S., Zalcenstein, D. A., Goldfinger, N., Zundelevich, A. et al. (2012) Epigenetic polymorphism and the stochastic formation of differentially methylated regions in normal and cancerous tissues. Nat. Genet., 44, 1207-1214.
43. Lienert, F., Wirbelauer, C., Som, I., Dean, A., Mohn, F. and Schubeler, D. (2011) Identification of genetic elements that autonomously determine DNA methylation states. Nat. Genet., 43, 1091-1097.
44. Macleod, D., Charlton, J., Mullins, J. and Bird, A. P. (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8, 2282-2292.
45. Blasco, M. A. (2005) Telomeres and human disease: ageing, cancer and beyond. Nat. Rev. Genet., 6, 611-622.
46. Milyavsky, M., Shats, I., Erez, N., Tang, X., Senderovich, S., Meerson, A., Tabach, Y., Goldfinger, N., Ginsberg, D., Harris, C. C. et al. (2003) Prolonged culture of telomerase-immortalized human fibroblasts leads to a premalignant phenotype. Cancer Res., 63, 7147-7157.